Atalanta Therapeutics
Boston, United States· Est.
Atalanta Therapeutics is developing RNAi therapeutics for genetically defined neurodegenerative diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $97M
About
Atalanta Therapeutics is developing RNAi therapeutics for genetically defined neurodegenerative diseases.
NeuroscienceRNA TherapeuticsRare Disease
Funding History
1Total raised:$97M
Series A$97M